Cargando…
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice
Cannabidiol (CBD) is currently being investigated as a novel therapeutic for the treatment of CNS disorders like schizophrenia and epilepsy. ABC transporters such as P-glycoprotein (P-gp) and breast cancer resistance protein (Bcrp) mediate pharmacoresistance in these disorders. P-gp and Bcrp are exp...
Autores principales: | Brzozowska, Natalia, Li, Kong M., Wang, Xiao Suo, Booth, Jessica, Stuart, Jordyn, McGregor, Iain S., Arnold, Jonathon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888295/ https://www.ncbi.nlm.nih.gov/pubmed/27257556 http://dx.doi.org/10.7717/peerj.2081 |
Ejemplares similares
-
Managing migraine with over-the-counter provision of triptans: the perspectives and readiness of Western Australian community pharmacists
por: Booth, Shaid, et al.
Publicado: (2019) -
Building interpretable models for polypharmacy prediction in older chronic patients based on drug prescription records
por: Kocbek, Simon, et al.
Publicado: (2018) -
Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines
por: Feinshtein, Valeria, et al.
Publicado: (2013) -
Retrospective cohort study of anti-tumor necrosis factor agent use in a veteran population
por: Bounthavong, Mark, et al.
Publicado: (2014) -
Swedish high-school pupils’ attitudes towards drugs in relation to drug usage, impulsiveness and other risk factors
por: Mousavi, Fariba, et al.
Publicado: (2014)